Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedle triamcinolone patch versus needle injection for alopecia areata
IRCT20250228064873N3Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of triamcinolone in alopecia areata (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Increase in Severity of Alopecia Tool score. Started Oct 2025; status: completed.
02
Drugs
triamcinolone
03
Conditions
alopecia areata
Beyond the preview
Go deeper on IRCT20250228064873N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250228064873N3.